Our cosmetic ingredient development team is prepared to lead discussions on next-generation cosmetics at SCS Formulate 2024, scheduled for November 12-13 in Coventry, UK.
If you’re curious about the buzz surrounding exosomes in cosmetic products, we invite you to join us for an in-depth exploration of extracellular particles during our presentation.
We will clarify the terminology surrounding exosomes, discuss essential quality control measures to ensure product integrity, and share insights on effectively incorporating exosomes into your formulations while avoiding common pitfalls. This presentation will equip you with the knowledge needed to harness the true power of exosomes in your products.
About Exolitus
At Exolitus, we leverage the exceptional potential of both vesicular and non-vesicular extracellular particles (EPs), particularly exosomes, to develop innovative solutions for the pharmaceutical, cosmeceutical, and nutraceutical industries. Our skincare innovations are based on the scalable production of exosomes derived from milk, plants and mushrooms.
Each of these exosomes, whether native or bioengineered, is optimized for therapeutic and bioactive applications, unlocking significant benefits in skincare, wellness, and medical treatments.
Commitment to Scientific Excellence and Quality Control
Our commitment to scientific excellence and stringent quality control remains unwavering. Our team of scientists, many of whom are active members of the International Society of Extracellular Vesicles (ISEV), ensures that every batch of exosomes meets the highest industry standards through a rigorous multi-step quality control process.
Visit Us at Stand 300
We encourage attendees of SCS Formulate 2024 to visit our booth (Stand 300) to learn more about our groundbreaking innovations and discuss potential collaborations.